GALMED PHARMACEUTICALS LTD. Foreign Currency Transaction Gain (Loss), before Tax
GALMED PHARMACEUTICALS LTD. (GLMD) reported Foreign Currency Transaction Gain (Loss), before Tax of $76.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-03-31
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 12 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month as first filed |
|---|---|---|
| 2025-12-31 | $76.00K 20-F · filed 2026-03-31 | |
| 2024-12-31 | -$40.00K 20-F · filed 2026-03-31 | |
| 2023-12-31 | $36.00K 20-F · filed 2026-03-31 | |
| 2022-12-31 | -$36.00K 20-F · filed 2025-04-02 | |
| 2021-12-31 | $25.00K 20-F · filed 2024-04-04 | |
| 2020-12-31 | $119.00K 20-F · filed 2023-03-29 | -$119.00K 20-F · filed 2021-03-18 |
| 2019-12-31 | $111.00K 20-F · filed 2022-05-02 | -$111.00K 20-F · filed 2020-03-12 |
| 2018-12-31 | $5.00K 20-F · filed 2021-03-18 | |
| 2017-12-31 | $94.00K 20-F · filed 2020-03-12 |